IP Verse

Miltenyi Biomedicine competitive analysis

Latest publications and patents of Miltenyi Biomedicine New

Explore the latest publications and patents granted to Miltenyi Biomedicine, showcasing their recent innovations and technological advancements.

Latest PTAB cases involving Miltenyi Biomedicine

Discover the latest PTAB cases involving Miltenyi Biomedicine, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 3, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Miltenyi Biomedicine

IPR2023-00760Mar 22, 2023MILTENYI BIOMEDICINEFRED HUTCHINSON CANCER CENTERInstitution Denied
IPR2022-00855Apr 12, 2022MILTENYI BIOMEDICINETHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIATerminated-Settled
IPR2022-00853Apr 12, 2022MILTENYI BIOMEDICINENOVARTIS PHARMAInstitution Denied
IPR2022-00852Apr 12, 2022MILTENYI BIOMEDICINETHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIATerminated-Settled

Peer Comparison New

IP litigation analysis comparing Miltenyi Biomedicine with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
MILTENYI BIOMEDICINE - - 4 - Highly Aggressive
FRED HUTCHINSON CANCER CENTER - 9 - 1Non-Active
NOVARTIS PHARMA - - - 4Non-Active
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA - 38 - 7Non-Active